1982The Japanese Journal of PharmacologyOpen access

BIPHASIC ACTION OF PENTAZOCINE IN MORPHINE-DEPENDENT RATS

Eijiro Tagashira, Tomoko URANO, Tameo Hiramori, Saizo YANAURA

Open full text 0 citations

Abstract

The characteristic actions of pentazocine in morphine-dependent rats were investigated by a drug-admixed food (DAF) method. Pentazocine did not cause evident withdrawal signs when stopped after a continuous administration for 2 months at 3 different dose levels. A state of physical dependency on morphine was produced in rata by feeding them for 3 weeks with food that contained different levels of morphine. Animals exhibiting a moderate degree of morphine-withdrawal signs (17—18 hr after withdrawal) received a s.c. cross-administration with pentazocine at 0, 5. 10, 20, 40, 80, and 150 mg/kg. This drug at 20 mg/kg proved most supressive of morphine-withdrawal signs, being about 1/4 as potent as codeine. In a dose range from 20 to 40 mg/kg. the action of pentazocine on the withdrawal signs was reversed, that Is, doses not less than 40 mg/kg exerted a dose-related antagonistic action in all the 3 levels of morphine dependent rats. The challenge with levallorphan {2 mg/kg, s.c.) during the chronic application of pentazocine revealed slight withdrawal signs. These findings show that pentazocine has biphasic action on morphine dependence and suggests that this type of drug must have different properties from morphine type drugs.

About this research paper

What this paper is about

The characteristic actions of pentazocine in morphine-dependent rats were investigated by a drug-admixed food (DAF) method. Pentazocine did not cause evident withdrawal signs when stopped after a continuous administration for 2 months at 3 different dose levels. A state of physical dependency on morphine was produced in rata by feeding them for 3 weeks with food that contained different levels of morphine. Animals exhibiting a moderate degree of morphine-withdrawal signs (17—18 hr after withdrawal) received a s.c. cross-administration with pentazocine at 0, 5. 10, 20, 40, 80, and 150 mg/kg. This drug at 20 mg/kg proved most supressive of morphine-withdrawal signs, being about 1/4 as potent as codeine. In a dose range from 20 to 40 mg/kg. the action of pentazocine on the withdrawal signs was reversed, that Is, doses not less than 40 mg/kg exerted a dose-related antagonistic action in all the 3 levels of morphine dependent rats. The challenge with levallorphan {2 mg/kg, s.c.) during the chronic application of pentazocine revealed slight withdrawal signs. These findings show that pentazocine has biphasic action on morphine dependence and suggests that this type of drug must have different properties from morphine type drugs.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The characteristic actions of pentazocine in morphine-dependent rats were investigated by a drug-admixed food (DAF) method. Pentazocine did not cause evident withdrawal signs when stopped after a continuous administration for 2 months at 3 different dose levels. A state of physical dependency on morphine was produced in rata by feeding them for 3 weeks with food that contained different levels of morphine. Animals exhibiting a moderate degree of morphine-withdrawal signs (17—18 hr after withdrawal) received a s.c. cross-administration with pentazocine at 0, 5. 10, 20, 40, 80, and 150 mg/kg. This drug at 20 mg/kg proved most supressive of morphine-withdrawal signs, being about 1/4 as potent as codeine. In a dose range from 20 to 40 mg/kg. the action of pentazocine on the withdrawal signs was reversed, that Is, doses not less than 40 mg/kg exerted a dose-related antagonistic action in all the 3 levels of morphine dependent rats. The challenge with levallorphan {2 mg/kg, s.c.) during the chronic application of pentazocine revealed slight withdrawal signs. These findings show that pentazocine has biphasic action on morphine dependence and suggests that this type of drug must have different properties from morphine type drugs.

Key concepts: Pentazocine, Morphine, Pharmacology, Physical dependence, Analgesic, Drug, Codeine, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
BIPHASIC ACTION OF PENTAZOCINE IN MORPHINE-DEPENDENT RATS — Research Paper | ScholarLens